Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

By Kasimir-Bauer S.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 123-132

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Melatonin Levels: Possible Link Between Parkinson’s Disease and Cancer Risk?

By Schernhammer Eva   Chen Honglei   Ritz Beate  

Cancer Causes and Control, Vol. 17, Iss. 4, 2006-05 ,pp. : 577-582

Springer Publishing Company

Access to resources Recommend Favorite

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

By Qin Ya-Zhen   Zhu Hong-Hu   Liu Yan-Rong   Wang Ya-Zhe   Shi Hong-Xia   Lai Yue-Yun   Xu Lan-Ping   Liu Dai-Hong   Jiang Qian   Li Ling-Di   Jiang Bin   Liu Kai-Yan   Huang Xiao-Jun  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1442-1449

Informa Healthcare

Access to resources Recommend Favorite

Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy

By Agostini Marco  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2461-2468

Springer Publishing Company

Access to resources Recommend Favorite

Minimal Residual Disease in Breast Cancer

By Kvalheim G.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 1, 1999-01 ,pp. : 101-108

Springer Publishing Company

Access to resources Recommend Favorite